newsfilter
← Latest News
PR Newswire·

Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today reported...